2007
DOI: 10.1126/science.1141736
|View full text |Cite
|
Sign up to set email alerts
|

Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

Abstract: Many potential treatments for Alzheimer's disease target amyloid-beta peptides (Abeta), which are widely presumed to cause the disease. The microtubule-associated protein tau is also involved in the disease, but it is unclear whether treatments aimed at tau could block Abeta-induced cognitive impairments. Here, we found that reducing endogenous tau levels prevented behavioral deficits in transgenic mice expressing human amyloid precursor protein, without altering their high Abeta levels. Tau reduction also pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

98
1,555
5
8

Year Published

2009
2009
2020
2020

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 1,709 publications
(1,690 citation statements)
references
References 30 publications
98
1,555
5
8
Order By: Relevance
“…Possibly related to this effect—and consistent with the observation that reduction of endogenous tau blocks network hyperexcitability and epilepsy of diverse causes 50, 67, 83, 84, 85—both hTau‐WT mice and hTau‐A152T mice were more susceptible to chemically induced epileptiform activity. Similar findings were obtained in hippocampal slice cultures from an independent hTau‐A152T mouse model 74 and in hTau mice carrying the FTDP‐17 mutations G272V, P301L, and R406W 86.…”
Section: Discussionsupporting
confidence: 81%
“…Possibly related to this effect—and consistent with the observation that reduction of endogenous tau blocks network hyperexcitability and epilepsy of diverse causes 50, 67, 83, 84, 85—both hTau‐WT mice and hTau‐A152T mice were more susceptible to chemically induced epileptiform activity. Similar findings were obtained in hippocampal slice cultures from an independent hTau‐A152T mouse model 74 and in hTau mice carrying the FTDP‐17 mutations G272V, P301L, and R406W 86.…”
Section: Discussionsupporting
confidence: 81%
“…6B and C). Similarly, ablation of the microtubule‐associated protein tau, which has been shown to reduce epileptic activity in a variety of seizure models,28, 30, 31, 32, 33, 34 tended to reduce interictal events by roughly 50% but, if anything, tended to slightly increase the left shift in spectral power in SYN mice (Fig. 6D and E).…”
Section: Resultsmentioning
confidence: 76%
“…Tau absence confers neuroprotection in several models of neuronal damage, such as traumatic brain injury (Cheng et al , 2014), neuroinflammation (Maphis et al , 2015), amyloid β‐mediated excitotoxicity (Roberson et al , 2007, 2011; Ittner et al , 2010; Vossel et al , 2010), and epilepsy (Holth et al , 2013), among others. Given that acute stress negatively affects AHN (Gould et al , 1992) and considering the neuroprotection exerted by the lack of Tau in the aforementioned models, we addressed whether the Porsolt test would cause similar detrimental effects in Tau −/− and WT mice.…”
Section: Discussionmentioning
confidence: 99%